Switzerland · 
Who invested in MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics's investors include Cormorant Asset Management, Hercules Capital and RTW Investments LLC.
2026
$75MRound$200MRound
Switzerland · Funded startup
Who invested in MoonLake Immunotherapeutics
Funding summaryUpdated 26 Oct 2026
$275Mraised across 2 rounds since 2025, from 2 sources
$75MRound$200MRound
- Latest round
- Round, $200MJun 2026
- Step-upi
- 2.7×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $75M Nov 2025
- Biggest round
- $200M Round · Jun 2026
- Between rounds
- 7 months from the last two
The rounds
- Jun 2026
- Nov 2025
Founders and team
From MoonLake Immunotherapeutics's own website: 2 founders, 18 on the team.
Jorge Santos da SilvaChairman & Chief Executive Officer, Founder
Kristian ReichFounder & Chief Scientific Officer
- Eva CullenVice-President Medical Affairs & Research
- Joana CortezAssociate Vice-President Legal & Compliance
- João NevesAssociate Vice-President IT
- Kate Wright Ph.D.Associate Vice-President Quality & PMO
- Luciana MarquesAssociate Vice-President of HR, People and Culture
- Matthias BodenstedtChief Financial Officer
- Nuala BrennanChief Clinical Development Officer
- Oliver DaltropChief Technical Officer
- Roman Akbar-HaaseChief of Staff to the Executive Board
- Wulf BoecherChief Medical Officer
- Alex GodwoodExecutive Director Biometrics
- Andrew J. PhillipsChairperson of The Compensation Committee
- Catherine MoukheibirChairperson of The Audit Committee
- Mark AntiolaSenior Director Finance
- Martin YatemanSenior Director Bioanalysis Clinical Development
- Nicolas MosimannGeneral Counsel
- Ramnik XavierDirector
- Spike LoyLead Independent Director
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about MoonLake Immunotherapeutics
How much has MoonLake Immunotherapeutics raised?
MoonLake Immunotherapeutics has raised $275M across 2 rounds since 2025.
When did MoonLake Immunotherapeutics last raise?
MoonLake Immunotherapeutics's most recent round was an Undisclosed round of $200M in Jun 2026.
What was MoonLake Immunotherapeutics's biggest round?
Its most recent round, $200M in Jun 2026, is also its largest on record.
Who backed MoonLake Immunotherapeutics first?
MoonLake Immunotherapeutics's first round on record, in Nov 2025, was backed by Cormorant Asset Management, Hercules Capital and RTW Investments LLC.
What stage is MoonLake Immunotherapeutics at?
MoonLake Immunotherapeutics's latest named round is an Undisclosed round, in Jun 2026.
Where is MoonLake Immunotherapeutics based?
MoonLake Immunotherapeutics is based in Switzerland.
Companies like MoonLake Immunotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.